Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wei Mu

Showing results (541-550 of 542) with videos related to

Pageof 55
Sort By:
You have reached the last page of results.This site can display upto 542 results.
Journal of Hepatology|January 21, 2019
Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational studyQiuhe Wang, Dongdong Xia, Wei Bai, et al.
Signal Transduction and Targeted Therapy|February 8, 2023
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)Hai-Dong Zhu, Hai-Liang Li, Ming-Sheng Huang, et al.
Pageof 55

Showing results (541-550 of 542) with videos related to

Sort By:
Pageof 55
You have reached the last page of results.This site can display upto 542 results.
Journal of Hepatology|January 21, 2019
Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational studyQiuhe Wang, Dongdong Xia, Wei Bai, et al.
Signal Transduction and Targeted Therapy|February 8, 2023
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)Hai-Dong Zhu, Hai-Liang Li, Ming-Sheng Huang, et al.
Pageof 55